The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany

Background: Antigen-based rapid diagnostic tests (Ag-RDT) have been implemented in hospitals and nursing homes to screen for infectious individuals without symptoms suggestive of SARS-CoV-2 infections and to prevent entry into these high-risk settings. Despite their benefits for screening, the cost...

Full description

Saved in:
Bibliographic Details
Main Authors: Valenzuela Hurtado, Alfonso (Author) , Nguyen, Hoa Thi (Author) , Schenkel, Viktoria (Author) , Wachinger, Jonas (Author) , Seybold, Joachim (Author) , Denkinger, Claudia M. (Author) , De Allegri, Manuela (Author)
Format: Article (Journal)
Language:English
Published: 2022
In: Health economics review
Year: 2022, Volume: 12, Issue: 1, Pages: 1-10
ISSN:2191-1991
DOI:10.1186/s13561-022-00361-3
Subjects:
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s13561-022-00361-3
Verlag, kostenfrei: https://link.springer.com/content/pdf/10.1186/s13561-022-00361-3.pdf
Resolving-System, kostenfrei: https://hdl.handle.net/10419/285252
Get full text
Author Notes:Alfonso Valenzuela Hurtado, Hoa Thi Nguyen, Viktoria Schenkel, Jonas Wachinger, Joachim Seybold, Claudia M. Denkinger and Manuela De Allegri

MARC

LEADER 00000caa a2200000 c 4500
001 179601124X
003 DE-627
005 20240403141919.0
007 cr uuu---uuuuu
008 220318s2022 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13561-022-00361-3  |2 doi 
024 7 |a 10419/285252  |2 hdl 
035 |a (DE-627)179601124X 
035 |a (DE-599)KXP179601124X 
035 |a (OCoLC)1361713726 
035 |a (DE-He213)s13561-022-00361-3-e 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Valenzuela Hurtado, Alfonso  |e VerfasserIn  |0 (DE-588)1254521143  |0 (DE-627)1796996408  |4 aut 
245 1 4 |a The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings  |b evidence from Germany  |c Alfonso Valenzuela Hurtado, Hoa Thi Nguyen, Viktoria Schenkel, Jonas Wachinger, Joachim Seybold, Claudia M. Denkinger and Manuela De Allegri 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.03.2022 
506 0 |q DE-206  |a Open Access  |e Controlled Vocabulary for Access Rights  |u http://purl.org/coar/access_right/c_abf2 
520 |a Background: Antigen-based rapid diagnostic tests (Ag-RDT) have been implemented in hospitals and nursing homes to screen for infectious individuals without symptoms suggestive of SARS-CoV-2 infections and to prevent entry into these high-risk settings. Despite their benefits for screening, the cost of large-scale implementation is largely understudied. Our study presents evidence on their implementation costs in high-risk settings. This study aimed to estimate the economic costs of implementing Ag-RDT-based screening for SARS-CoV-2 in two tertiary care hospitals (University Hospital Heidelberg - UKHD, and Charité - Universitätsmedizin Berlin) and one nursing home in Germany. Methods: We adopted a health system perspective and followed the three sequential steps to costing: identification of resources, measurement of resource consumption, and valuation of costs. Data on resource consumption were collected between October 2020 and April 2021 through various techniques and data sources. The cost estimation considered all costs along the screening algorithm including PCR confirmation tests for positive cases. We estimated the costs for the two implementation modalities observed: staff dedicated exclusively to screening and staff not dedicated exclusively to screening. Furthermore, cost estimations were performed under both observed capacity use and hypothetical capacity use assumptions (60, 80 and 100%). Results: Our study indicates that the average cost per Ag-RDT is highly dependent on the capacity use and implementation mode. Staff time and test kits are the two main cost drivers of implementing the large-scale screening programs for SARS-CoV-2 using Ag-RDTs. For hospitals, the average cost per test in UKHD was €30.12 (capacity observed); €14.56 (non-dedicated mode); €19.47, €16.37, €14.53 at 60, 80, 100% capacity respectively (dedicated mode); and at Charité €13.10 (non-dedicated mode). For the nursing home the estimated average cost per test was €15.03 (non-dedicated mode). Conclusions: The information on the estimated costs by mode of implementation and capacity use may support the planning of Ag-RDT-based covid-19 screening programs suitable for each institution. Further research is needed to cost this screening strategy for COVID-19 in other high-risk, high-income settings to reach generalizability. 
540 |q DE-206  |a Namensnennung 4.0 International  |f CC BY 4.0  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
650 4 |a Antigen-based rapid diagnostic test 
650 4 |a Germany 
650 4 |a Implementation costs 
650 4 |a SARS-CoV-2 
650 4 |a Screening 
650 4 |a Antigen-based rapid diagnostic test  |7 (dpeaa)DE-206 
650 4 |a SARS-CoV-2  |7 (dpeaa)DE-206 
650 4 |a Screening  |7 (dpeaa)DE-206 
650 4 |a Implementation costs  |7 (dpeaa)DE-206 
650 4 |a Germany  |7 (dpeaa)DE-206 
655 4 |0 (DE-206)49  |a Aufsatz in Zeitschrift  |5 DE-206 
700 1 |a Nguyen, Hoa Thi  |d 1980-  |e VerfasserIn  |0 (DE-588)114906613X  |0 (DE-627)1009349880  |0 (DE-576)496533169  |4 aut 
700 1 |a Schenkel, Viktoria  |e VerfasserIn  |4 aut 
700 1 |a Wachinger, Jonas  |d 1994-  |e VerfasserIn  |0 (DE-588)1217607749  |0 (DE-627)1731778899  |4 aut 
700 1 |a Seybold, Joachim  |e VerfasserIn  |0 (DE-588)1013340337  |0 (DE-627)664158803  |0 (DE-576)346946638  |4 aut 
700 1 |a Denkinger, Claudia M.  |d 1978-  |e VerfasserIn  |0 (DE-588)131597701  |0 (DE-627)511279469  |0 (DE-576)298613727  |4 aut 
700 1 |a De Allegri, Manuela  |d 1975-  |e VerfasserIn  |0 (DE-588)131974904  |0 (DE-627)516328913  |0 (DE-576)298870975  |4 aut 
773 0 8 |i Enthalten in  |t Health economics review  |d Heidelberg : Springer, 2011  |g 12(2022), 1 vom: Dez., Artikel-ID 15, Seite 1-10  |h Online-Ressource  |w (DE-627)670605115  |w (DE-600)2634483-X  |w (DE-576)354003127  |x 2191-1991  |7 nnas  |a The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings evidence from Germany 
773 1 8 |g volume:12  |g year:2022  |g number:1  |g month:12  |g elocationid:15  |g pages:1-10  |a The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings evidence from Germany 
856 4 0 |u https://doi.org/10.1186/s13561-022-00361-3  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/content/pdf/10.1186/s13561-022-00361-3.pdf  |x Verlag  |z kostenfrei 
856 4 0 |u https://hdl.handle.net/10419/285252  |x Resolving-System  |z kostenfrei 
951 |a AR 
992 |a 20230109 
993 |a Article 
994 |a 2022 
998 |g 131974904  |a De Allegri, Manuela  |m 131974904:De Allegri, Manuela  |d 910000  |d 912800  |d 50000  |e 910000PD131974904  |e 912800PD131974904  |e 50000PD131974904  |k 0/910000/  |k 1/910000/912800/  |k 0/50000/  |p 7  |y j 
998 |g 131597701  |a Denkinger, Claudia M.  |m 131597701:Denkinger, Claudia M.  |d 910000  |d 911700  |d 50000  |e 910000PD131597701  |e 911700PD131597701  |e 50000PD131597701  |k 0/910000/  |k 1/910000/911700/  |k 0/50000/  |p 6 
998 |g 1217607749  |a Wachinger, Jonas  |m 1217607749:Wachinger, Jonas  |d 910000  |d 911700  |e 910000PW1217607749  |e 911700PW1217607749  |k 0/910000/  |k 1/910000/911700/  |p 4 
998 |g 114906613X  |a Nguyen, Hoa Thi  |m 114906613X:Nguyen, Hoa Thi  |d 50000  |e 50000PN114906613X  |k 0/50000/  |p 2 
999 |a KXP-PPN179601124X  |e 4245103922 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"179601124X","name":{"displayForm":["Alfonso Valenzuela Hurtado, Hoa Thi Nguyen, Viktoria Schenkel, Jonas Wachinger, Joachim Seybold, Claudia M. Denkinger and Manuela De Allegri"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"relHost":[{"recId":"670605115","physDesc":[{"extent":"Online-Ressource"}],"disp":"The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings evidence from GermanyHealth economics review","origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisherPlace":"Heidelberg","publisher":"Springer"}],"pubHistory":["1.2011 -"],"id":{"zdb":["2634483-X"],"eki":["670605115"],"issn":["2191-1991"],"hdl":["10419/76676"]},"part":{"year":"2022","pages":"1-10","issue":"1","volume":"12","text":"12(2022), 1 vom: Dez., Artikel-ID 15, Seite 1-10"},"title":[{"title_sort":"Health economics review","title":"Health economics review"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 25.06.13"]}],"person":[{"display":"Valenzuela Hurtado, Alfonso","role":"aut","given":"Alfonso","family":"Valenzuela Hurtado"},{"display":"Nguyen, Hoa Thi","role":"aut","given":"Hoa Thi","family":"Nguyen"},{"role":"aut","given":"Viktoria","family":"Schenkel","display":"Schenkel, Viktoria"},{"display":"Wachinger, Jonas","role":"aut","given":"Jonas","family":"Wachinger"},{"display":"Seybold, Joachim","family":"Seybold","role":"aut","given":"Joachim"},{"role":"aut","given":"Claudia M.","family":"Denkinger","display":"Denkinger, Claudia M."},{"display":"De Allegri, Manuela","family":"De Allegri","role":"aut","given":"Manuela"}],"id":{"eki":["179601124X"],"hdl":["10419/285252"],"doi":["10.1186/s13561-022-00361-3"]},"title":[{"subtitle":"evidence from Germany","title_sort":"economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings","title":"The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 30.03.2022"]} 
SRT |a VALENZUELAECONOMICCO2022